Anavex Life Sciences Corp (AVXL)

[falconer66a]

Dizziness Would Not Be a Prohibiting Approval Factor

Should anyone think infrequent cases of dizziness by those taking the most concentrated doses of Anavex 2-73 might keep the FDA from approving the drug, take the time tonight to watch not only the evening news on any of the three networks, but watch the many FDA-approved drugs being advertised. Listen carefully, and try to read the fine print at the bottom of the ad frames. You might wonder how these drugs ever got approved.

Almost all of these wonderful drugs can have severe, even lethal side effects. But dizziness is virtually never mentioned as a matter of concern.

The fact of the matter is this. The frequency and severity of adverse events (side effects) in humans taking prescribed doses of Anavex 2-73 are mild and relatively infrequent. They will in no way complicate or prohibit FDA approval of the drug.